Calpain-dependent regulation of the skeletal muscle atrophy following unloading

Arch Biochem Biophys. 2015 Oct 15:584:36-41. doi: 10.1016/j.abb.2015.07.011. Epub 2015 Aug 18.

Abstract

Unloading causes rapid skeletal muscle atrophy due to increased protein degradation via activation of calpains and decreased protein synthesis. Our study elucidated role of calpain-1 in the regulation of ubiquitin proteasome pathway (UPP) and anabolic processes mediated by Akt-mTOR-p70S6K and MAPK-Erk (p90RSK) signaling. We hypothesized that blocking calpain will inhibit activation of UPP and decrease protein degradation resulting in reduction of unloading-induced skeletal muscle atrophy. Rats were divided into three groups: non-treated control (C), three day hindlimb suspension with (HSPD) or without (HS) treatment with calpain inhibitor PD150606. When compared with control PD150606 treatment during unloading: 1) attenuated loss of muscle mass, 2) prevented accumulation of calpain-1 (1.8-fold in HS vs 1.3-fold in HSPD) and ubiquitin (2.3-fold in HS vs 0.7-fold in HSPD) mRNA and ubiquitinated proteins (1.6-fold in HS vs 0.8-fold in HSPD), 3) prevented decrease in the pAkt (0.4-fold in HS vs 1-fold in HSPD) and pFOXO3 (0.2-fold in HS vs 1.2-fold in HSPD) levels, 4) prevented increase in MAFbx (3.8-fold in HS vs 1.3-fold in HSPD) and eEF2k (1.8-fold in HS vs 0.6-fold in HSPD) mRNA. Our study indicates that blocking of calpain during unloading decreases skeletal muscle atrophy by inhibiting UPP activation and preserving anabolic signaling.

Keywords: Calpain; MAFbx; Skeletal muscle unloading; Ubiquitin proteasome pathway; pFOXO3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acrylates / pharmacology*
  • Animals
  • Calpain / antagonists & inhibitors
  • Calpain / metabolism*
  • Immobilization
  • MAP Kinase Signaling System / drug effects*
  • Male
  • Muscle Proteins / antagonists & inhibitors
  • Muscle Proteins / metabolism*
  • Muscular Atrophy / drug therapy
  • Muscular Atrophy / metabolism*
  • Muscular Atrophy / pathology
  • Proteolysis / drug effects*
  • Rats
  • Rats, Wistar

Substances

  • Acrylates
  • Muscle Proteins
  • PD 150606
  • Calpain